Smoking and mental health - NCSCT

More documents

Recommendations

Info

Smoking and mental health 59 Vieyra-Reyes P, Mineur YS, Picciotto MR, et al. Antidepressant-like effects of nicotine and transcranial magnetic stimulation in the olfactory bulbectomy rat model of depression. Brain Research Bulletin 2008;77:13–8. 60 Andreasen JT, Henningsen K, Bate S, Christiansen S, Wiborg O. Nicotine reverses anhedonic-like response and cognitive impairment in the rat chronic mild stress model of depression: comparison with sertraline. Journal of Psychopharmacology 2010;25:1134–41. 61 Tronci V, Balfour DJ. The effects of the mGluR5 receptor antagonist 6-methyl-2- (phenylethynyl)-pyridine (MPEP) on the stimulation of dopamine release evoked by nicotine in the rat brain. Behavioural Brain Research 2011;219:354–7. 62 Palmatier MI, Liu X, Caggiula AR, Donny EC, Sved AF. The role of nicotinic acetylcholine receptors in the primary reinforcing and reinforcement-enhancing effects of nicotine. Neuropsychopharmacology 2007;32:1098–108. 63 Palmatier MI, Matteson GL, Black JJ, et al. The reinforcement enhancing effects of nicotine depend on the incentive value of non-drug reinforcers and increase with repeated drug injections. Drug and Alcohol Dependence 2007;89:52–9. 64 Bozarth MA, Pudiak CM, KuoLee R. Effect of chronic nicotine on brain stimulation reward. I. Effect of daily injections. Behavioural Brain Research 1998;96:185–8. 65 Clarke PB, Kumar R. Effects of nicotine and d-amphetamine on intracranial selfstimulation in a shuttle box test in rats. Psychopharmacology 1984;84:109–14. 66 Kenny PJ, Markou A. Nicotine self-administration acutely activates brain reward systems and induces a long-lasting increase in reward sensitivity. Neuropsychopharmacology 2006;31:1203–11. 67 Nestler EJ, Carlezon WA, Jr. The mesolimbic dopamine reward circuit in depression. Biological Psychiatry 2006;59:1151–9. 68 Paterson NE, Markou A. Animal models and treatments for addiction and depression comorbidity. Neurotoxin Research 2007;11:1–32. 69 Benwell ME, Balfour DJ, Khadra LF. Studies on the influence of nicotine infusions on mesolimbic dopamine and locomotor responses to nicotine. Clinical Investigations 1994;72:233–9. 70 Turner JR, Castellano LM, Blendy JA. Nicotinic partial agonists varenicline and sazetidine- A have differential effects on affective behavior. Journal of Pharmacology and Experimental Therapeutics 2010;334:665–72. 71 Mineur YS, Picciotto MR. Nicotine receptors and depression: revisiting and revising the cholinergic hypothesis. Trends in Pharmacological Science 2010;31:580–6. 72 Simon NM. Generalized anxiety disorder and psychiatric comorbidities such as depression, bipolar disorder, and substance abuse. Journal of Clinical Psychiatry 2009;70(suppl 2):10–4. 73 Brioni JD, O’Neill AB, Kim DJ, et al. Anxiolytic-like effects of the novel cholinergic channel activator ABT-418. Journal of Pharmacology and Experimental Therapeutics 1994;271:353–61. 74 Turner JR, Castellano LM, Blendy JA. Parallel anxiolytic-like effects and upregulation of neuronal nicotinic acetylcholine receptors following chronic nicotine and varenicline. Nicotine and Tobacco Research 2010;13:41–6. 75 Vale AL, Green S. Effects of chlordiazepoxide, nicotine and d-amphetamine in the rat potentiated startle model of anxiety. Behavioural Pharmacology 1996;7:138–43. 76 Balfour DJ, Graham CA, Vale AL. Studies on the possible role of brain 5-HT systems and adrenocortical activity in behavioural responses to nicotine and diazepam in an elevated X-maze. Psychopharmacology 1986;90:528–32. 56 © Royal College of Physicians 2013
Neurobiological and behavioural mechanisms linking smoking and mental disorders 3 77 Caldarone BJ, King SL, Picciotto MR. Sex differences in anxiety-like behavior and locomotor activity following chronic nicotine exposure in mice. Neuroscience Letters 2008;439:187–91. 78 Ouagazzal AM, Kenny PJ, File SE. Modulation of behaviour on trials 1 and 2 in the elevated plus-maze test of anxiety after systemic and hippocampal administration of nicotine. Psychopharmacology 1999;144:54–60. 79 Biala G, Budzynska B. Effects of acute and chronic nicotine on elevated plus maze in mice: involvement of calcium channels. Life Sciences 2006 30;79:81–8. 80 Benwell ME, Balfour DJ. Effects of nicotine administration and its withdrawal on plasma corticosterone and brain 5-hydroxyindoles. Psychopharmacology 1979;63:7–11. 81 Buczek Y, Le AD, Wang A, Stewart J, Shaham Y. Stress reinstates nicotine seeking but not sucrose solution seeking in rats. Psychopharmacology 1999;144:183–8. 82 Martin-Garcia E, Barbano MF, Galeote L, Maldonado R. New operant model of nicotineseeking behaviour in mice. International Journal of Neuropsychopharmacology 2009;12:343–56. 83 Jonkman S, Risbrough VB, Geyer MA, Markou A. Spontaneous nicotine withdrawal potentiates the effects of stress in rats. Neuropsychopharmacology 2008;33:2131–8. 84 O’Dell LE, Khroyan TV. Rodent models of nicotine reward: what do they tell us about tobacco abuse in humans? Pharmacology, Biochemistry and Behavior 2009;91:481–8. 85 Kalman D. The subjective effects of nicotine: methodological issues, a review of experimental studies, and recommendations for future research. Nicotine and Tobacco Research 2002;4:25–70. 86 Kalman D, Smith SS. Does nicotine do what we think it does? A meta-analytic review of the subjective effects of nicotine in nasal spray and intravenous studies with smokers and nonsmokers. Nicotine and Tobacco Research 2005;7:317–33. 87 Salin-Pascual RJ, de la Fuente JR, Galicia-Polo L, Drucker-Colin R. Effects of transderman nicotine on mood and sleep in nonsmoking major depressed patients. Psychopharmacology 1995;121:476–9. 88 Salin-Pascual RJ, Drucker-Colin R. A novel effect of nicotine on mood and sleep in major depression. NeuroReport 1998;9:57–60. 89 Salin-Pascual RJ, Rosas M, Jimenez-Genchi A, Rivera-Meza BL, Delgado-Parra V. Antidepressant effect of transdermal nicotine patches in nonsmoking patients with major depression. Journal of Clinical Psychiatry 1996;57:387–9. 90 Cox LS, Patten CA, Krahn LE, et al. The effect of nicotine patch therapy on depression in nonsmokers: a preliminary study. Journal of Addictive Disease 2003;22:75–85. 91 McClernon FJ, Hiott FB, Westman EC, Rose JE, Levin ED. Transdermal nicotine attenuates depression symptoms in nonsmokers: a double-blind, placebo-controlled trial. Psychopharmacology 2006;189:125–33. 92 Gilbert DG, Robinson JH, Chamberlin CL, Spielberger CD. Effects of smoking/nicotine on anxiety, heart rate, and lateralization of EEG during a stressful movie. Psychophysiology 1989;26:311–20. 93 Levin ED, Conners CK, Silva D, Canu W, March J. Effects of chronic nicotine and methylphenidate in adults with attention deficit/hyperactivity disorder. Experimental and Clinical Psychopharmacology 2001;9:83–90. 94 Jamner LD, Shapiro D, Jarvik ME. Nicotine reduces the frequency of anger reports in smokers and nonsmokers with high but not low hostility: an ambulatory study. Experimental and Clinical Psychopharmacology 1999;7:454–63. 95 Kassel JD, Unrod M. Smoking, anxiety, and attention: support for the role of nicotine in attentionally mediated anxiolysis. Journal of Abnormal Psychology 2000;109:161–6. © Royal College of Physicians 2013 57
Page 1 and 2:
PDF not for circulation Smoking and
Page 3 and 4:
Contents Members of the Tobacco Adv
Page 5 and 6:
Contents 4.4.3 Attention deficit hy
Page 7 and 8:
Contents 6.4.3 Staff knowledge 122
Page 9 and 10:
Contents 10.5 Tobacco policy and me
Page 11 and 12:
Contributors Anthony Aclet - Specia
Page 13 and 14:
Contributors Jill Williams - Associ
Page 15 and 16:
1 Mental disorders 1.1 What is a me
Page 17 and 18:
Mental disorders 1 1.3 Common menta
Page 19 and 20: Mental disorders 1 1.4.4 Somatisati
Page 21 and 22: Mental disorders 1 In addition to s
Page 23 and 24: Mental disorders 1 not diagnosed un
Page 25 and 26: Mental disorders 1 Similar to many
Page 27 and 28: Mental disorders 1 12 Chang CK, Hay
Page 29 and 30: Mental disorders 1 52 Young S, Toon
Page 31 and 32: Smoking among people with mental di
Page 53 and 54: Neurobiological and behavioural mec
Page 69: Neurobiological and behavioural mec
Page 77 and 78: Epidemiology of the association bet
Page 99 and 100: Smoking cessation interventions for
Page 121 and 122:
Smoking cessation interventions for
Page 123 and 124:
Smoking cessation interventions for
Page 125 and 126:
6 Population strategies to prevent
Page 127 and 128:
Population strategies to prevent sm
Page 129 and 130:
Page 131 and 132:
Page 133 and 134:
Page 135 and 136:
Page 137 and 138:
Page 139 and 140:
Page 141 and 142:
Page 143 and 144:
Page 145 and 146:
Smoking and mental disorders: speci
Page 147 and 148:
Page 149 and 150:
Page 151 and 152:
Page 153 and 154:
Page 155 and 156:
Page 157 and 158:
Page 159 and 160:
Page 161 and 162:
Page 163 and 164:
Page 165 and 166:
Page 167 and 168:
Page 169 and 170:
Page 171 and 172:
Page 173 and 174:
Page 175 and 176:
Page 177 and 178:
Page 179 and 180:
The economic cost of smoking in peo
Page 181 and 182:
Page 183 and 184:
Page 185 and 186:
Page 187 and 188:
Page 189 and 190:
Page 191 and 192:
Page 193 and 194:
Page 195 and 196:
Page 197 and 198:
Ethical and legal aspects 9 pose co
Page 199 and 200:
Ethical and legal aspects 9 less an
Page 201 and 202:
Ethical and legal aspects 9 patient
Page 203 and 204:
10 Summary and conclusions 10.1 Smo
Page 205 and 206:
Summary and conclusions 10 10.4 Smo
Page 207 and 208:
Summary and conclusions 10 although
Page 209 and 210:
11 Key conclusions and recommendati
Page 211 and 212:
Key conclusions and recommendations
Page 213 and 214:
Page 215:
show all

Smoking and mental health - NCSCT

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?